Jabodon PT Co’s Ovintiv OVV Stock Holding History

Jabodon PT Co’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-56,519	Closed	-$1.63M	–	33
2018 Q4	$1.63M	Buy	+56,519	New	+$2.44M	1.5%	20
2018 Q2	–	Sell	-62,385	Closed	-$3.43M	–	17
2018 Q1	$3.43M	Sell	62,385 -53,404	-46%	-$3.17M	3.1%	10
2017 Q4	$7.72M	Buy	+115,789	New	+$6.83M	5.96%	4

Other funds holding OVV

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jabodon PT Co's OVV Position: Q1 2019 in Review

Jabodon PT Co sold out of Ovintiv (OVV) in Q1 2019, closing a stake of 56,519 shares — an estimated $1.63M sold.

Jabodon PT Co first reported a position in OVV in Q4 2017 and held it in 3 quarters. The position peaked at $7.72M in Q4 2017. 506 funds tracked by Wall St. Rank hold OVV as of Q1 2019.

Jabodon PT Co reported no remaining Ovintiv position as of Q1 2019 after selling out during the quarter.
Jabodon PT Co sold 56,519 Ovintiv shares in Q1 2019, an estimated $1.63M.
Jabodon PT Co first reported a position in Ovintiv in Q4 2017 and held it in 3 quarters.
Jabodon PT Co's Ovintiv position peaked at $7.72M in Q4 2017.
506 funds tracked by Wall St. Rank held Ovintiv as of Q1 2019.

Based on Jabodon PT Co's 13F filing for Q1 2019, filed 10 May 2019.